Significant Ownership of MANGROVE PARTNERS IM, LLC

Signature - Title
Nathaniel August - Nathaniel August, President
Location
Greenwich, CT
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by MANGROVE PARTNERS IM, LLC.

Follow Filing Activity

Follow MANGROVE PARTNERS IM, LLC and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Significant Ownership of MANGROVE PARTNERS IM, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ANEB Anebulo Pharmaceuticals, Inc. Common Stock 6.2% $2,979,797 2,525,252 Mangrove Partners IM, LLC 31 Dec 2024
CHPG ChampionsGate Acquisition Corp Class A ordinary shares, par value $0.0001 per share 5.7% $4,936,076 491,641 Mangrove Partners IM, LLC 30 Sep 2025
MREO Mereo BioPharma Group plc American Depositary Shares, each representing five ordinary shares, nominal value of (pound)0.003 per share 4.9% $80,242,974 38,952,900 Mangrove Partners IM, LLC 30 Sep 2025
AOGO AROGO CAPITAL ACQUISITION CORP. Class A Common Stock, $0.0001 par value per share 4.5% $2,745,140 217,523 Mangrove Partners IM, LLC 31 Dec 2024

Schedules 13D/G Reported by MANGROVE PARTNERS IM, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .